By: Ainsley Brown The Swiss pharmaceutical giant Novartis has launched suit in the English High Court against Glaxo Smith Kline (GSK) claiming that GSK has violated its intellectual property. This new action is far from being the opening salvos of this drug war; the two have already locked horns over the same matter. GSK last year sued Novartis in both